COLOR-VISION DEFICIENCIES AND ENHANCED SE NSITIVITY TO GLARE IN EPILEPTIC PATIENTS TREATED WITH CARBAMAZEPINE AND PHENYTOIN - OCULAR SIDE-EFFECTS OF ANTIEPILEPTIC DRUG
A. Bayer et al., COLOR-VISION DEFICIENCIES AND ENHANCED SE NSITIVITY TO GLARE IN EPILEPTIC PATIENTS TREATED WITH CARBAMAZEPINE AND PHENYTOIN - OCULAR SIDE-EFFECTS OF ANTIEPILEPTIC DRUG, Nervenarzt, 66(2), 1995, pp. 89-96
Advanced psychophysical tests, performed in 42 epileptic patients, sho
w that the antiepileptic drugs phenytoin and carbamazepine can specifi
cally affect the retinal function, while Valproic Acid and the epilept
ic seizures do not. The Farnsworth-Munsell 100-Hue and Panel D-15 desa
ture tests revealed an accumulation of errors along the tritan/tetarta
n axis (blue colour vision deficiences) and a high total error score.
The same defect was shown by measurement of the spectral sensitivity f
unctions. The results obtained for mesopic vision and especially glare
sensitivity measured by nyktometry were markedly affected in these pa
tients compared to a normal population. The enhanced sensitivity to gl
are is mainly the only one symptom complained by the patient. We propo
se a screening method for early detection of phenytoin- and carbamazep
ine-induced neurotoxicity. The literature of ocular side effects of an
ticonvulsant drugs is carefully reviewed.